SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Malaria science advances amid eradication pessimism
Fri August 23rd - British scientists have unveiled major discoveries about malaria – as the World Health Organisation warned the disease would not be eradicated in the near future. More
Polypill success at preventing cardiovascular diseases
Fri August 23rd - A low-cost polypill, which combines four cardiovascular drugs into a single pill, has cut the risk of major cardiovascular events in the first trial of its kind, researchers report today. More
Half hour daily activity backed in new analysis
Fri August 23rd - People who undertake daily physical activity, regardless of intensity, may gain the optimal health benefits, researchers have reported. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Statins failing half of patients – but do they take them?

Tuesday April 16th, 2019

Half of patients prescribed statins do not achieve the necessary “healthy” cholesterol levels after two years of treatment, according to a new observational study.

The researchers, whose findings are published online today (15 April 2019) in the latest edition of Heart, say their analysis backs up previous studies and highlights the need for personalised medicine to tackle high cholesterol.

GP leaders said they believed the problem lay with patients failing to take the drugs regularly.

In the UK, the National Institute for Health and Care Excellence (NICE) says that statins should achieve a reduction of 40% or more of LDL cholesterol – but this study showed that only half of patients responded.

The researchers drew on diagnostic and prescribing data submitted anonymously by 681 family doctor practices to the UK Clinical Practice Research Datalink - and linked them to episodes of hospital treatment (HES data) and statistics on cause of death (ONS data).

Complete information was available for 165,411 patients and the researchers found that there was a suboptimal response in 84,609 patients (51%) when it came to achieving a 40% reduction in LDL cholesterol.

Patients who failed to reach the 40% reduction after two years were 22% more likely to develop cardiovascular disease than those who did respond well.

Every 1 mmol/l fall in low density cholesterol was associated with a 6% lower risk of stroke and mini stroke in those who failed to reach the 40% target.

“Currently, there is no management strategy in clinical practice which takes into account patient variations in response, and no guidelines for predictive screening before commencement of statin therapy,” say the researchers.

“These findings contribute to the debate on the effectiveness of statin therapy and highlight the need for personalised medicine in lipid management for patients.”

Royal College of GPs chair Professor Helen Stokes-Lampard said: “There is a substantial body of research showing that statins are safe and effective drugs for most people, and can reduce the risk of heart attacks and stroke, when prescribed appropriately – but controversy remains around their widespread use and their potential side-effects.

“There are complex reasons why patients choose not to take their prescribed medication, and mixed messaging around statins could be one of these.

“We would encourage anyone who is on regular medication to attend their scheduled medication reviews and to raise any queries or concerns they might have. But given the widespread GP shortages and intense workload pressures that we currently have in general practice, it’s hard to know what more we can do to encourage greater compliance with medications that have been recommended in good faith.”

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart 16 April 2019; doi 10.1136/heartjnl-2018-314253

http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2018-314253

Tags: Diet & Food | Heart Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES